For laboratory research use only · Not for human or veterinary use · 18+
Growth hormone research

Buy Tesamorelin Ipamorelin Blend in Australia

Lyophilised powder, 13 + 3mg vial · Available to order, dispatched from Australia
$159.99

Buy Tesamorelin Ipamorelin in Australia from Macropus Peptides as one research vial holding 13mg of Tesamorelin and 3mg of Ipamorelin, freeze-dried together. Tesamorelin is a full-length growth hormone releasing hormone analogue acting on the GHRH receptor, and Ipamorelin is a selective agonist of the ghrelin receptor, so the pair lets a laboratory study both pituitary inputs from one preparation. The vial is priced and in stock, and it costs the same as a single 10mg Tesamorelin vial while holding more Tesamorelin plus the Ipamorelin, which makes it the cheaper route when both compounds are needed at this ratio. Each vial is sealed and labelled with both compounds, the amount of each, lot number and storage temperature, and the lot's certificate of analysis is available on request. The two single peptides are also stocked for control arms. Add bacteriostatic water and the order ships from local Australian stock to any Australian address, for in-vitro research by adults 18 and over only, never for human or veterinary use.

1
Frequently bought together
Ipamorelin 10mg$109.99
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
CompoundTesamorelin + Ipamorelin
Amount13 + 3 mg
FormLyophilised powder
CategoryGrowth hormone research
Storage-20 °C, protect from light
TestingHPLC purity 98% or higher and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label
Peptide calculator

Tesamorelin + Ipamorelin 13 + 3mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Vial content
16 mg
mg per mL8.00
mcg per mL8,000

Buy Tesamorelin Ipamorelin Blend Australia: 13mg + 3mg in One Vial

Macropus Peptides supplies this two-peptide research vial at a set price: 13 milligrams of Tesamorelin and 3 milligrams of Ipamorelin in a single freeze-dried cake, 16 milligrams in all. It exists for laboratories that study the two pituitary receptors for growth hormone release together and want one lot number, one reconstitution and one ratio that never drifts between preparations. Both components are made to the same specification as our single vials.

Tesamorelin + Ipamorelin Australia: what the blend contains

The vial pairs two peptides from opposite sides of growth hormone control. Tesamorelin is all 44 amino acids of human growth hormone releasing hormone with a trans-3-hexenoyl cap on the first residue, which protects it from DPP-4, the enzyme that inactivates the natural hormone. Ipamorelin is a five amino acid agonist of the ghrelin receptor, first described in 1998 as the earliest selective growth hormone secretagogue. Neither peptide is changed by being combined; they are simply dried together at a mass ratio of 13 to 3, and that split is printed on the label. Neither is an approved medicine in Australia, and the combination has never been registered anywhere.

How Tesamorelin and Ipamorelin work together in research

Growth hormone cells in the pituitary answer to two separate receptors. The GHRH receptor works through the Gs protein and cyclic AMP; the ghrelin receptor, also called the growth hormone secretagogue receptor, works through Gq and calcium. Stimulating both at once produces a bigger growth hormone response than either can manage alone, an effect studied in pituitary research for decades. Choosing this particular pair also has a logic: Tesamorelin is the GHRH analogue with the largest clinical record, and Ipamorelin is the ghrelin-side peptide with the narrowest effect on cortisol and prolactin, so the combined signal stays focused on growth hormone.

In a model system, the Tesamorelin half raises cyclic AMP in somatotrophs and primes growth hormone synthesis, while the Ipamorelin half triggers the calcium signal that releases stored hormone. Researchers use the blend to measure how the two signals add together, how quickly the response returns to baseline, and how downstream IGF-1 output follows. Because the release still runs through the pituitary, somatostatin and IGF-1 feedback remain intact, which keeps the model closer to physiology than direct growth hormone addition.

Tesamorelin and Ipamorelin research: what the studies show

Each component has its own published record. The receptor that Ipamorelin targets was cloned in 1996 (Science), and the peptide itself was characterised in 1998 (European Journal of Endocrinology) as a secretagogue that released growth hormone without raising ACTH or cortisol in animal models. Tesamorelin's own evidence base includes randomised trials from 2007 (New England Journal of Medicine) and 2014 (JAMA), both measuring visceral and liver fat in adults with HIV, and a pooled phase 3 analysis (Journal of Clinical Endocrinology and Metabolism, 2010) tracked IGF-1 alongside body composition. Published work on the two in one preparation is limited, which is why combination research remains largely preclinical. Our combination research studies library lists the papers behind each component.

Tesamorelin + Ipamorelin vial specifications

SpecificationDetail
CompoundTesamorelin + Ipamorelin
Amount13 + 3 mg
FormLyophilised powder
CategoryGrowth hormone research
Storage-20 °C, protect from light

The two peptides share one lyophilised cake in a stoppered, crimped glass vial. Its label lists both compound names with their individual masses, 13mg and 3mg, plus the lot number and storage temperature. Its matching analysis certificate reports both components; quote the lot number and we send it. Freezer storage at -20 °C, in the carton, protects the unopened blend, and a 2 to 8 °C fridge holds it once water has gone in.

Tesamorelin Ipamorelin price in Australia: value per milligram of each peptide

StrengthPricePrice per mg
Tesamorelin + Ipamorelin 13 + 3mg$159.99$10.00 per mg

The blend sells for the same checkout price as one 10mg Tesamorelin vial, yet holds 13mg of Tesamorelin plus 3mg of Ipamorelin. Measured per milligram of Tesamorelin alone, that already undercuts the 2mg, 5mg and 10mg single fills, and the Ipamorelin comes on top at no extra cost. Only the 20mg single vial is cheaper per milligram of Tesamorelin, and it carries no Ipamorelin. Buying the two peptides as separate 10mg vials would cost well over one and a half times as much for a paired study.

Tesamorelin Ipamorelin 13 + 3mg: the molar ratio and when to buy singles

The 16mg vial is the only size of this blend, and it covers a set of paired experiments on one lot, with both compounds released from the same cake whenever it is reconstituted. The ratio looks lopsided by mass but not by molecule. Tesamorelin weighs about 5,136 daltons and Ipamorelin about 712, so 13mg is roughly 2.5 micromoles of the GHRH analogue and 3mg is roughly 4.2 micromoles of the pentapeptide, close to three ghrelin-side molecules for every two on the GHRH side.

Buying a single Tesamorelin vial plus a separate Ipamorelin vial adds weighing and mixing steps where error can creep in. The singles still earn their place: a control arm that needs one peptide alone, or a study where the ratio itself is the variable, needs them. For a GHRH partner with a shorter backbone, the CJC-1295 and Ipamorelin blend swaps Tesamorelin for CJC-1295 no DAC.

Best place to buy Tesamorelin Ipamorelin in Australia

  • Sold online at macropuspeptides.com, priced at $159.99
  • Every batch HPLC tested to 98% or higher purity, with identity confirmed by mass spectrometry
  • A certificate of analysis for every lot, matched to the lot number printed on the label
  • Same-day dispatch from Australian stock for orders paid before 2pm AEST on a business day
  • Tracked delivery Australia wide: standard in 2 to 5 working days, express in 1 to 2 working days
  • Payment by PayID or bank transfer, with your order ID as the reference

How to order Tesamorelin + Ipamorelin online

  • Add the 13mg plus 3mg vial to your cart
  • Add the single peptides if a control arm needs them
  • Put bacteriostatic water in the order for reconstitution
  • Tick the over-18 and bench-use boxes while paying
  • File the lot number that arrives on the label

Tesamorelin and Ipamorelin calculator: bac water for the 16mg vial

Because the vial holds two compounds, work out each one. With 2 mL of bacteriostatic water, every millilitre carries 6.5mg of Tesamorelin and 1.5mg of Ipamorelin (8 mg per mL combined). A 3 mL volume is the tidiest for the pentapeptide, giving exactly 1mg of it per millilitre beside about 4.33mg of Tesamorelin. With 4 mL, each millilitre carries 3.25mg and 0.75mg (4 mg per mL combined). The ratio stays at 13 to 3 whatever volume you choose. Order bacteriostatic water with the blend so both arrive together.

Is Tesamorelin Ipamorelin available in Australia

Here the combination trades purely as research material. Neither peptide appears on the ARTG, and the blend is not an approved product anywhere, so no sale for people or animals is allowed. Both releasing factors and secretagogues for growth hormone fall under TGA scheduling, and the latest Poisons Standard text governs what your organisation may hold.

Tesamorelin Ipamorelin blend for sale Australia wide: onshore dispatch

Blend parcels are boxed at our Australian base for laboratories in Adelaide, Sydney, Hobart, Perth, Canberra, Brisbane, Melbourne, Darwin and across the mainland and Tasmania, so nothing waits on international freight. Further combinations and singles sit within the growth hormone research range, including CJC-1295 with DAC for continuous GHRH exposure.

References

  1. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996.
  2. Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology. 1998.
  3. Metabolic effects of a growth hormone-releasing factor in patients with HIV. New England Journal of Medicine. 2007.
  4. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. Journal of Clinical Endocrinology and Metabolism. 2010.
  5. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Research guides on Tesamorelin + Ipamorelin 13 + 3mg

Questions about Tesamorelin + Ipamorelin 13 + 3mg

Chat on WhatsApp
Tesamorelin + Ipamorelin 13 + 3mg$159.99